Sex, academics, and dermatology leadership: progress made, but no more excuses.
Kimball, Alexa Boer. 2012. “Sex, Academics, and Dermatology Leadership: Progress Made, But No More Excuses.”. Archives of Dermatology 148 (7): 844-6.
Search
Search results
2993 results found
Career trajectory and job satisfaction trends in Mohs micrographic surgeons.
Tierney, Emily P, William Hanke, and Alexa Boer Kimball. 2011. “Career Trajectory and Job Satisfaction Trends in Mohs Micrographic Surgeons.”. Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.] 37 (9): 1229-38.
Reduction in the appearance of facial hyperpigmentation after use of moisturizers with a combination of topical niacinamide and N-acetyl glucosamine: results of a randomized, double-blind, vehicle-controlled trial.
Kimball, A B, J R Kaczvinsky, J Li, L R Robinson, P J Matts, C A Berge, K Miyamoto, and D L Bissett. 2010. “Reduction in the Appearance of Facial Hyperpigmentation After Use of Moisturizers With a Combination of Topical Niacinamide and N-Acetyl Glucosamine: Results of a Randomized, Double-Blind, Vehicle-Controlled Trial.”. The British Journal of Dermatology 162 (2): 435-41.
Long-term safety of biologics in dermatology.
Lima, Xinaida T, Elizabeth M Seidler, Hermênio C Lima, and Alexandra B Kimball. 2009. “Long-Term Safety of Biologics in Dermatology.”. Dermatologic Therapy 22 (1): 2-21.
Acne and oral contraceptives: update on women's health screening guidelines.
Frangos, Jason E, Christina N Alavian, and Alexa B Kimball. 2008. “Acne and Oral Contraceptives: Update on Women’s Health Screening Guidelines.”. Journal of the American Academy of Dermatology 58 (5): 781-6.
Alefacept for erosive lichen planus: a case series.
Chang, Anne Lynn S, Joanna Badger, Wingfield Rehmus, and Alexa Boer Kimball. 2008. “Alefacept for Erosive Lichen Planus: A Case Series.”. Journal of Drugs in Dermatology : JDD 7 (4): 379-83.
Risk of COVID-19 in dermatologic patients receiving long-term immunomodulatory therapy.
Holcomb, Zachary E, Monica Rosales Santillan, Peyton C Morss-Walton, Prerna Salian, Min Ji Her, Nicole M Giannotti, Alexa B Kimball, and Martina L Porter. 2020. “Risk of COVID-19 in Dermatologic Patients Receiving Long-Term Immunomodulatory Therapy.”. Journal of the American Academy of Dermatology 83 (4): 1215-18.
Assessment of the effects of immunogenicity on the pharmacokinetics, efficacy and safety of tildrakizumab.
Kimball, A B, T Kerbusch, F van Aarle, P Kulkarni, Q Li, A Blauvelt, K A Papp, K Reich, and D Montgomery. 2020. “Assessment of the Effects of Immunogenicity on the Pharmacokinetics, Efficacy and Safety of Tildrakizumab.”. The British Journal of Dermatology 182 (1): 180-89.
Managing the dose escalation of biologics in an era of cost containment: the need for a rational strategy.
Shahwan, K T, and A B Kimball. 2016. “Managing the Dose Escalation of Biologics in an Era of Cost Containment: The Need for a Rational Strategy.”. International Journal of Women’s Dermatology 2 (4): 151-53.
A Closer Inspection of the Number Needed to Biopsy-Reply.
Shahwan, Kathryn T, and Alexa B Kimball. 2016. “A Closer Inspection of the Number Needed to Biopsy-Reply.”. JAMA Dermatology 152 (8): 953.